[1]曾胜澜,王娜,张荣臻,等.基于网络药理学探讨茵黄解毒汤治疗HBV相关肝衰竭的活性成分及其作用机制[J].西部中医药,2024,37(02):91-98.[doi:10.12174/j.issn.2096-9600.2024.02.18]
　ZENG Shenglan,WANG Na,ZHANG Rongzhen,et al.Active Components and Its Molecular Mechanism of Yinhuang Jiedu Decoction in the Treatment of HBV - related Liver Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(02):91-98.[doi:10.12174/j.issn.2096-9600.2024.02.18]
点击复制

基于网络药理学探讨茵黄解毒汤治疗HBV相关肝衰竭的活性成分及其作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年02期
页码:
91-98
栏目:
二次研究
出版日期:
2024-02-15

文章信息/Info

Title:
Active Components and Its Molecular Mechanism of Yinhuang Jiedu Decoction in the Treatment of HBV - related Liver Failure Based on Network Pharmacology
作者:
曾胜澜1, 王娜1, 张荣臻1, 王挺帅2, 吴聪3, 毛德文1
1.广西中医药大学第一附属医院，广西 南宁 530023
2.湖南中医药大学，湖南 长沙 410000
3.广西中医药大学，广西 南宁 530023
Author(s):
ZENG Shenglan1, WANG Na1, ZHANG Rongzhen1, WANG Tingshuai2, WU Cong3, MAO Dewen1
1.First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530023, China
2.Hunan University of Chinese Medicine, Changsha 410000, China
3.Guangxi University of Traditional Chinese Medicine, Nanning 530023, China
关键词:
网络药理学; 茵黄解毒汤; 乙型肝炎病毒; 相关肝衰竭
Keywords:
network pharmacology; decoction; hepatitis B virus; related liver failure
分类号:
R512.6+2
DOI:
10.12174/j.issn.2096-9600.2024.02.18
文献标志码:
A
摘要:
目的采用网络药理学方法研究茵黄解毒汤治疗乙型肝炎病毒（hepatitis B virus，HBV）相关肝衰竭（hepatitis B virus related liver failure，HBV-LF）的活性成分及其分子机制。 方法采用GEO数据库筛选疾病相关差异基因（differentially expressed genes，DEGs），TCMSP数据库筛选中药复方小分子化合物及其作用靶点，Venny 2.1.0进行交集比对，确定交集靶点及其关系。运用Cytoscape构建茵黄解毒汤治疗HBV-LF的调控网络，Bisogenet构建蛋白互作网络（protein-protein interaction network，PPI），CytoNCA进行网络拓扑学分析。利用David数据库进行GO富集分析和KEGG信号通路富集分析。 结果本研究共得到HBV-LF的差异基因2160个，茵黄连解毒汤的药物靶点255个，交集靶点31个，相关小分子化合物66个。小分子化合物包括槲皮素、山柰酚、黄芩素、芦荟大黄素、黄连素等。PPI网络涉及55个关键节点，包括TP53、NTRK1、HSP90AA1、ESR1、CUL3、MCM2、CDK2、HSP90AB1、YWHAZ、NPM1、EGFR等。GO富集分析主要与细胞组分构成或来源、对刺激的反应、免疫过程、正/负调节的生物过程、细胞死亡、细胞增殖等有关。KEGG通路27条，主要涉及PI3K-Akt信号通路、MAPK信号通路、Cell cycle、Hepatitis B、自噬、FoxO信号通路、Ras信号通路、IL-17信号通路、NOD样受体信号通路、HIF-1信号通路、NF-κB信号通路等。 结论茵黄解毒汤拮抗HBV-LF具有“多靶点-多通路-多作用”的特性，其作用机制可能与促进肝细胞增殖分化、降低肝细胞凋亡、调节机体免疫、抑制HBV复制等有关。
Abstract:
ObjectiveTo study the active ingredients of Yinhuang Jiedu decoction in the treatment of hepatitis B virus (HBV)-related liver failure (HBV-LF) and its molecular mechanism using network pharmacology. MethodsGEO was used to screen DEGs, TCMSP database to sift small molecule compound of TCM compounds and the targets of action, Venny 2.1.0 to perform the intersection comparison, identifying intersecting targets and their relationships. Cytoscape was applied to build the regulation network of Yinhuang Jiedu decoction in the treatment of HBV-LF, Bisogenet to construct PPI, CytoNCA to perform network topology analysis. David database to conduct GO enrichment analysis and KEGG signaling pathway enrichment analysis. ResultsThe study gained 2160 DEGs of HBV-LF, 255 targets of Yinhuang Jiedu decoction, 31 intersecting targets and 66 relevant small molecular compounds. Small molecular compounds included quercetin, kaempferol, baicalein, aloe barbadensis, canthaxanthin, etc. PPI network involved 55 key links, covering TP53, NTRK1, HSP90AA1, ESR1, CUL3, MCM2, CDK2, HSP90AB1, YWHAZ, NPM1, EGFR and others. GO enrichment analysis is mainly connected with cellular component composition or the source, the response to the stimuli, immunologic process, biological process of positive/negative regulation, cellular death, cellular proliferation. All 27 KEGG pathways mainly refer to PI3K-Akt signal pathway, MAPK signaling pathway, Cell cycle, Hepatitis B, autophagy, FoxO signaling pathway, Ras signaling pathway, IL-17 signaling pathway, NOD-like receptor signaling pathway, HIF-1 signaling pathway and NF-κB signaling pathway. ConclusionYinhuang Jiedu decoction could treat HBV-LF from multi-target, multi-pathway and multi-effect, and its mechanism might be related to promoting the proliferation and differentiation of hepatocyte, reducing the apoptosis of hepatocyte, regulating body immunity and inhibiting the replication of HBV.

相似文献/References:

[1]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[2]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[3]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[4]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[5]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(02):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[6]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[7]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(02):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[8]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
　LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
[9]潘威.基于网络药理学探讨大黄治疗溃疡性结肠炎的机制[J].西部中医药,2022,35(06):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
　PAN Wei.The Mechanism of Dahuang in Treating Ulcerative Colitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
[10]李磊,宁南义,王小龙,等.基于网络药理学的新型冠状病毒肺炎核心中药靶标预测及其作用机制研究?[J].西部中医药,2021,34(11):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]
　LI Lei,NING Nanyi,WANG Xiaolong,et al.The Study on the Mechanism and Target Prediction of Core Herbs of COVID-19 Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(02):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]

备注/Memo

备注/Memo:
曾胜澜（1996—），女，硕士学位。研究方向：肝病的中医药防治及研究。国家自然科学基金（81960841，81774236，82060848）；国家中医药管理局“慢性重型肝炎解毒化瘀”重点研究室项目；广西自然科学基金（2020JJA140273）；广西中医药大学校级一般硕士研究生创新项目（YCSY2020011）。
更新日期/Last Update: 2024-02-15